Zydus Cadila said on 25 June it has signed an agreement for acquiring 100% stake in the Brazilian firm, Nikkho, to mark its foray into Brazil’s branded generics market.
“Nikkho’s well entrenched presence will help Zydus Cadila in launching ‘branded speciality’ products aggressively across Brazil and enable it to step up the registration process of several molecules,” Zydus Cadila chairman and managing director Pankaj R Patel said in a release.
He said the foray in the branded generics segment is expected to fetch better margins and earnings.The acquisition is being made through Zydus Healthcare Brasil Limitada, a wholly owned subsidiary of Cadila Healthcare but the company, however, did not disclose the investment being made in the process.
Read more in The Livemint article.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment